Skip to Content

Waters Corp WAT

Morningstar Rating
$294.40 +0.15 (0.05%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Waters Gearing Up for Improvement in Macro-Conditions Later in 2024

Waters helps clients perform scientific research by providing analytical instruments, services, and supplies. The company specializes in liquid chromatography and mass spectrometry products (nearly 90% of sales), which are used primarily by biopharmaceutical firms to analyze a molecule’s structure during the drug discovery, development, and production processes. These tools can also be used in food and environmental quality testing as well as other industrial applications, though. Also, Waters helps scientists examine the physical properties of various materials through its thermal analysis tools (low-double digits percentage).

Price vs Fair Value

WAT is trading at a 816% premium.
Price
$294.40
Fair Value
$437.00
Uncertainty
Medium
1-Star Price
$789.82
5-Star Price
$135.60
Economic Moat
Fbbmp
Capital Allocation
Srzprprgc

Bulls Say, Bears Say

Bulls

Waters' analytical instruments remain the gold standard in several applications, especially LC-MS for biopharmaceutical firms, where regulations preserve consistent recurring sales for many years.

Bears

Waters remains an extremely focused organization, which creates the potential for cash flow variability if its products fall out of favor.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if WAT is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$294.25
Day Range
$291.85296.88
52-Week Range
$231.90367.21
Bid/Ask
$117.76 / $360.00
Market Cap
$17.46 Bil
Volume/Avg
106 / 455,396

Key Statistics

Price/Earnings (Normalized)
25.06
Price/Sales
6.00
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
0.08%

Company Profile

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Mid Core
Total Number of Employees
7,900

Competitors

Valuation

Metric
WAT
A
TMO
Price/Earnings (Normalized)
25.0625.4026.33
Price/Book Value
13.906.334.77
Price/Sales
6.006.035.18
Price/Cash Flow
21.1621.2625.39
Price/Earnings
WAT
A
TMO

Financial Strength

Metric
WAT
A
TMO
Quick Ratio
1.391.491.19
Current Ratio
2.222.151.70
Interest Coverage
8.2815.344.83
Quick Ratio
WAT
A
TMO

Profitability

Metric
WAT
A
TMO
Return on Assets (Normalized)
17.19%14.45%8.69%
Return on Equity (Normalized)
88.59%26.40%18.71%
Return on Invested Capital (Normalized)
25.75%18.41%10.97%
Return on Assets
WAT
A
TMO
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
KnzgdjytbGxjt$217.3 Bil
Danaher Corp
DHR
ZcytkzhxdFbmbyv$190.7 Bil
IDEXX Laboratories Inc
IDXX
LqbztywlWjzdkq$41.6 Bil
Agilent Technologies Inc
A
DskknlrkwtTmsqd$39.4 Bil
IQVIA Holdings Inc
IQV
VhdsqqmjjPbpyqqr$38.8 Bil
Mettler-Toledo International Inc
MTD
XmtpjnljxNwcxjc$31.6 Bil
Icon PLC
ICLR
DswfcxvzNxgdzz$26.4 Bil
Labcorp Holdings Inc
LH
SfxnjxrmVqfjlqc$17.4 Bil
Illumina Inc
ILMN
HyvgntgvvJybvgp$17.2 Bil

Sponsor Center